chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Biopsy, Cellulitis, Erythema, Inflammation, Oral herpes
Clinical narrative: Information has been received from a 69 year old female patient with hypertension, arthritis, drug hypersensitivity to "NASOTEC", Prednisone, Piperacillin/ Tazobactam and a history of gastric bypass who in December 2007, was vaccinated with ZOSTAVAX (Merck). Concomitant therapy included Alprazolam, Estrogens, vitamins and minerals. In January 2009, the patient experienced a herpes lesion (cold sore) on her lip which had then expanded to the inside of her mouth. The patient said if felt like a "blister that won't open and is inflamed". The patient had been using hot compresses and had a biopsy by her plastic surgeon. She went to the ER as a result of complication of the biopsy. The patient had sought medical attention and was not recovered at the time of reporting. Follow up information has been received from a medical assistant concerning the 69 year old retired female patient with drug hypersensitivity to mylogram dye, enalapril maleate (MSD), Prednisone and Piperacillin / Tazobactam (ZOSYN) who on 07-Dec-2007 at 14:36 was vaccinated with ZOSTAVAX (Merck) subcutaneous injection into the left upper arm(lot# 68396/ 0967U). On 10-Dec-2007, the patient experienced redness and pain-increased pain with movement and cellulitis. She had sought medical attention and subsequently recovered. Follow up information has been received from a nurse that the 69 year old female patient had cellulitis at the site where the lesion was biopsied. The patient had pain with movement of her mouth at the time. The patient subsequently experienced allergy while on therapy with Enalapril maleate (MSD, WAES#0905USA02813) Additional information has been requested.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Oral pain
Clinical narrative: Information has been received from a 69 year old female patient with hypertension, arthritis, drug hypersensitivity to "NASOTEC", Prednisone, Piperacillin/ Tazobactam and a history of gastric bypass who in December 2007, was vaccinated with ZOSTAVAX (Merck). Concomitant therapy included Alprazolam, Estrogens, vitamins and minerals. In January 2009, the patient experienced a herpes lesion (cold sore) on her lip which had then expanded to the inside of her mouth. The patient said if felt like a "blister that won't open and is inflamed". The patient had been using hot compresses and had a biopsy by her plastic surgeon. She went to the ER as a result of complication of the biopsy. The patient had sought medical attention and was not recovered at the time of reporting. Follow up information has been received from a medical assistant concerning the 69 year old retired female patient with drug hypersensitivity to mylogram dye, enalapril maleate (MSD), Prednisone and Piperacillin / Tazobactam (ZOSYN) who on 07-Dec-2007 at 14:36 was vaccinated with ZOSTAVAX (Merck) subcutaneous injection into the left upper arm(lot# 68396/ 0967U). On 10-Dec-2007, the patient experienced redness and pain-increased pain with movement and cellulitis. She had sought medical attention and subsequently recovered. Follow up information has been received from a nurse that the 69 year old female patient had cellulitis at the site where the lesion was biopsied. The patient had pain with movement of her mouth at the time. The patient subsequently experienced allergy while on therapy with Enalapril maleate (MSD, WAES#0905USA02813) Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a consumer's husband concerning his wife with no pertinent medical history and no allergies who in approximately March 2009. "about a month ago" was vaccinated with ZOSTAVAX (Merck) by the intramuscular route. Concurrent therapy included Evista. The patient had been experiencing swelling and pain at the injection site, since the administration of ZOSTAVAX (Merck) at the same day as vaccination. The patient's events persisted. The patient sought medical attention and consulted with physician. No further information is available.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Injection site swelling, Injection site warmth, Varicella
Clinical narrative: Information has been received from a pharmacist concerning a 67 year old female with no known allergies or medical history reported, who on 24-APR-2009 was vaccinated SQ with a 0.65 ml dose of ZOSTAVAX (Merck) (date, dose and lot number unknown). There was not concomitant medication. The pharmacist reported, the patient developed an injection site reaction after receiving a dose of the vaccine (date unspecified). The patient reported that the site got hot and swollen about the size of 50 cents coin. The pharmacist had not seen the patient but he thought that it is chicken pox. The outcome of the patient was not recovered. the patient called the pharmacist for medical attention. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic
Clinical narrative: Information has been received from a pharmacist concerning a 60 year old female with liver disorder and no known allergies, who on 18-DEC-2008 was vaccinated with a single dose of ZOSTER vaccine live (Merck) (lot number: 662857/1560X), SQ in her left upper arm.  Concomitant therapy included HYDROCHLOROTHIAZIDE, PROPRANOLOL HC1 and LORAZEPAM (manufacturers unknown).  The pharmacist reported that on unspecified date the pharmacist reported, the patient developed an itchy rash in on of her arms, unspecified and both lower extremities (date unspecified).  The patient was examined by her physician and was prescribed TRIAMCINOLONE cream topically (manufacturer unknown) (dose and duration not reported).  The rash had persisted and worsens with exposure to heat.  The outcome of the patient was not recovered.  The patient had been referred to an unspecified dermatologist.  Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Local reaction, Pain, Swelling
Clinical narrative: Information has been received from a pharmacist concerning the pharmacist's 66 year old mother with no pertinent medical history who on 05-MAR-2008 was vaccinated with ZOSTAVAX (Merck) 0.65ml.  There was no concomitant medication. The week later after vaccination, the patient experienced localized reaction like redness, pain and swelling. On an unspecified date, the patient recovered from the events. The patient sought unspecified medical attention. This is one of several reports from the same source. Additional information has been requested.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Computerised tomogram abnormal, Herpes zoster, Pain, Post herpetic neuralgia, Rash erythematous
Clinical narrative: Information has been received from a physician concerning a 78 year old female who on 03-MAR-2009 (also reported as 30-MAR-2009) was subcutaneously vaccinated in the right arm with a first 0.65 ml dose of ZOSTAVAX (Merck) (lot # 663775/1789X). On 07-MAR-2009 the patient developed shingles after she had been given ZOSTAVAX (Merck). The shingles had "cleared up" but she presently had post herpetic neuralgia (PHN) ("10" on a 1-10 scale). At time of reporting, the patient was recovering. The patient sought unspecified medical attention. Follow-up information was received from a physician and medical records indicating this 78 year old female non-smoker who drinks one drink per day and has allergies to IMDUR and Sulfonamide, anaemia, coronary artery disease, atypical chest pain, gastrooesophageal reflux disease, transient global amnesia, anxiety, scoliosis, hypertension, cardiomyopathy, lung disorder and hyperlipidaemia and a history of erythematous papular eruption (approximately 20 years ago), chickenpox (1939), hysterectomy and an appendicectomy. The patient went to the emergency room on 07-MAR-2009 with complaints of left sided pain. No rash was noted by the emergency room physician on 07-MAR-2009. Urinalysis and laboratory values were normal. A CT scan of the abdomen and pelvis showed punctate calcification within the left kidney, representing a nonobstructing calculus; small cyst in the left kidney, stable from prior exam; hiatal hernia; trace left pleural fluid versus pleural thickening and chronic air space opacity in the left lower lobe. The lung findings were unchanged from prior scans. She was discharged to home in stable condition with VICODIN for pain. On 09-MAR-2009 she was seen at her primary care physician's office and an exam revealed a linear erythematous papular eruption on her left flank approximately 7 inches in length. She was prescribed ZOVIRAX 800 mg 5 times per day for 1 week. On 11-MAR-2009 the patient received a phone call from the emergency room and they stated she had a kidney infection. It was indicated it was "okay" for the patient to take CIPRO and the previous CT scan showed she did not have a kidney infection, but possible a bladder infection. On 16-MAR-2009 the patient finished her antiviral medication, but continued to have pain from the shingles and was prescribed PERCOCET 5/325 mg tablets 1 PO q 6 hours prn. On 23-MAR-2009 the patient continued to have pain from the shingles and was prescribed NEURONTIN 300 mg 1 cap PO daily for 1 week then 1 cap PO BID. On 03-APR-2009 the patient reported the NEURONTIN was "the best". On 01-MAY-2009 the NEURONTIN was stopped. A sample of the lesion was not collected. It was reported the patient recovered from post herpetic neuralgia (PHN). Additional information is not expected.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash papular
Clinical narrative: Information has been received from a physician concerning a 78 year old female who on 03-MAR-2009 (also reported as 30-MAR-2009) was subcutaneously vaccinated in the right arm with a first 0.65 ml dose of ZOSTAVAX (Merck) (lot # 663775/1789X). On 07-MAR-2009 the patient developed shingles after she had been given ZOSTAVAX (Merck). The shingles had "cleared up" but she presently had post herpetic neuralgia (PHN) ("10" on a 1-10 scale). At time of reporting, the patient was recovering. The patient sought unspecified medical attention. Follow-up information was received from a physician and medical records indicating this 78 year old female non-smoker who drinks one drink per day and has allergies to IMDUR and Sulfonamide, anaemia, coronary artery disease, atypical chest pain, gastrooesophageal reflux disease, transient global amnesia, anxiety, scoliosis, hypertension, cardiomyopathy, lung disorder and hyperlipidaemia and a history of erythematous papular eruption (approximately 20 years ago), chickenpox (1939), hysterectomy and an appendicectomy. The patient went to the emergency room on 07-MAR-2009 with complaints of left sided pain. No rash was noted by the emergency room physician on 07-MAR-2009. Urinalysis and laboratory values were normal. A CT scan of the abdomen and pelvis showed punctate calcification within the left kidney, representing a nonobstructing calculus; small cyst in the left kidney, stable from prior exam; hiatal hernia; trace left pleural fluid versus pleural thickening and chronic air space opacity in the left lower lobe. The lung findings were unchanged from prior scans. She was discharged to home in stable condition with VICODIN for pain. On 09-MAR-2009 she was seen at her primary care physician's office and an exam revealed a linear erythematous papular eruption on her left flank approximately 7 inches in length. She was prescribed ZOVIRAX 800 mg 5 times per day for 1 week. On 11-MAR-2009 the patient received a phone call from the emergency room and they stated she had a kidney infection. It was indicated it was "okay" for the patient to take CIPRO and the previous CT scan showed she did not have a kidney infection, but possible a bladder infection. On 16-MAR-2009 the patient finished her antiviral medication, but continued to have pain from the shingles and was prescribed PERCOCET 5/325 mg tablets 1 PO q 6 hours prn. On 23-MAR-2009 the patient continued to have pain from the shingles and was prescribed NEURONTIN 300 mg 1 cap PO daily for 1 week then 1 cap PO BID. On 03-APR-2009 the patient reported the NEURONTIN was "the best". On 01-MAY-2009 the NEURONTIN was stopped. A sample of the lesion was not collected. It was reported the patient recovered from post herpetic neuralgia (PHN). Additional information is not expected.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 62 year old male who on 25-FEB-2009 was subcutaneously vaccinated with a 0.65 ml dose of ZOSTAVAX  (Merck). On 02-MAR-2009 the patient developed shingles even though he had been given ZOSTAVAX (Merck). A couple of days after he got shingles, he recovered. The patient sought unspecified medical attention. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a 61 year old female with migraines, hypercholesterolaemia and allergy to bee stings and flu shots as well as a history of melanoma of right eye who on 14-APR-2009 was vaccinated subcutaneously with a dose of ZOSTAVAX (Merck) (lot# 663639/1707X).  Concomitant therapy included IMITREX.  On 15-APR-2009 the patient developed redness and induration that was 4 cm by 3 cm at the injection site.  She was seen by a physician on 16-APR-2009 and the affected area increased to 4 inches by 3 inches.  She was given KEFLEX.  The outcome was unknown.  Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Varicella
Clinical narrative: Information has been received from a Registered (R.N.) concerning a female with a history of 2 cases of childhood chickenpox who was vaccinated with a dose of ZOSTER vaccine live (Merck).  Recently the patient developed chickenpox.  VARICELLA-ZOSTER virus analysis was offered to pharmacist.  At the time of reporting the patient was not recovered.  Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia, Rash vesicular
Clinical narrative: Information has been received from a nurse practitioner (N.P.) concerning a male who on an unspecified date was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck). The N.P. reported that the patient developed shingles after he had been given ZOSTAVAX (Merck). The outcome was unknown. Unspecified medical attention was sought. Follow-up information was received from the nurse practitioner (N.P.) concerning the 79 year old male with hypertension, benign prostatic hyperplasia and aortic stenosis who on 29-NOV-2007 was vaccinated SC with a dose of ZOSTAVAX (Merck) (lot # 658839/1411U). Concomitant therapy included NORVASC, AVALIDE and NIASPAN. On 13-APR-2009 the patient developed vesicular rash at T5 right dermatome with 2 lesions on back and 1 lesion under right breast. The rash was resolving but the patient was experiencing post herpetic neuralgia which was rated 3/4/10. The patient was treated with gabapentin. Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a 71 year old female patient with history of shingles before vaccination and no known drug allergies/drug reactions who in "early January 2009" was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) subcutaneously. Concomitant therapy included KLOR-CON, levothyroxine, PREMARIN, lisinopril (manufacturer unknown) and lovastatin (manufacturer unknown). It was reported that in the "early part of February 2009" the patient experienced her first outbreak of shingles which "cleared up in about 3 days". It was reported that on 29-APR-2009 the patient experienced her second outbreak of shingles. The patient did not seek medical attention. There were no laboratory diagnostic tests performed. The outcome of the patient was unknown. Additional information has been requested.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Pain in extremity, Skin lesion
Clinical narrative: Information has been received from a physician concerning his 80 year old mother in law, who was vaccinated with a dose of ZOSTAVAX (Merck). After receiving the vaccine, the patient developed shingles. It was also reported that the patient's left arm was hurting. At the time of this report the patient had not recovered. The patient sought unspecified medical attention. Follow up information received on 08-MAY-2009 from the physician stated that the patient was a retired female with high blood pressure and a history of varicella zoster as a child. Concomitant therapy included MICARDIS. On 22-FEB-2009 the patient experienced pain under her left arm - between breast. On 27-FEB-2009 blisters/lesions appeared. She realized that it was shingles, the shingles spread around back. On 28-FEB-2009 the patient started VALTREX. The patient was taking pain pills at night, and a sleeping pill either TYLENOL or AMBIEN. On 05-MAY-2009 the patient was still experiencing pain under her left arm, but no rash or blisters. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Information has been received from a pharmacist concerning two patients who on an unknown date were vaccinated with a dose of ZOSTAVAX (Merck) (lot # not provided) for prevention of shingles. Subsequently, after receiving the vaccine the patients experienced rashes around the injection site. The patients sought pharmacist attention. Follow up information received on 07-MAY-2007 from the pharmacist stated that the patient was vaccinated on 21-APR-2009 with a dose of ZOSTAVAX (Merck) (lot # 664091/0140Y). This is one of two reports from the same source. Additional information has been requested.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash papular
Clinical narrative: Information has been received from a 63 year old male consumer with no pertinent medical history reported who on 23-AUG-2007 was vaccinated with a dose of ZOSTAVAX vaccine (Merck) (dose, route and lot number not provided). There was no concomitant medication. On 27-APR-2009 the patient's wife saw a spider bite looking bump on his arm and it started to spread on his arm. The patient reported that he was supposed to have an unspecified surgery on 29-APR-2009 but it was hold off because during the prescreening for surgery, they saw the bump and he was told to go back to his family physician to have the bump checked. the patient reported that his physician noted that this was shingles. At the time of reporting the patient had not recovered from the event. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: Information has been received from a nurse practitioner concerning a female who was vaccinated with a dose of ZOSTAVAX (Merck). The patient developed a severe case of shingles. The nurse could not confirm any information as she heard it "as second hand information through the grapevine" and never saw the patient. The product that was given was rumored to have a temperature excursion during a power outage. As it was told to her, the patient had to be given narcotics in an emergency room to control severe pain. Unknown if admitted. Attempts to verify the existence of an identifiable patient have been unsuccessful. Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site haematoma, Injection site pain
Clinical narrative: Information has been received from a 66 year old female with no pertinent medical history and no drug reactions or allergies won on 17-APR-2009 was vaccinated with a single dose of ZOSTAVAX (Merck). Concomitant therapy included LOTREL. The patient reported that "after getting the vaccine", she started experiencing really bad headaches that lasted about 8 days. She also mentioned that she experienced bruising and soreness at the injection site. The soreness and headaches went away, however, the bruising was still there. The patient sought unspecified medical attention. There were no lab diagnostics studies performed. Additional information has been requested.
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Accidental exposure, Injection site irritation
Clinical narrative: Information has been received from a nurse concerning a 82 old female patient with unspecified drug reactions/allergies and medical history who was vaccinated with a dose of ZOSTAVAX (Merck) (date, dose, route and lot number not reported).  There was no concomitant medication.  The nurse reported as she was administering the vaccine to a patient "part of medication leaked out of the syringe and dripped on the patient's arm".  The nurse also stated "the patient reported the medication burned as it was injected into her arm".  The patient was recovered.  The patient sought medical attention, she spoke with nurse.  Additional information has been requested.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash pruritic, Rash vesicular, Skin lesion, Varicella, Viral DNA test negative
Clinical narrative: Information has been received from a pharmacist concerning a 60 year old male with chest pain, obesity, gastrooesophageal reflux disease, vitamin B12 deficiency, tremor, post-traumatic stress disorder, dumping syndrome and a history of chickenpox as a child, a history of a drug reaction to etodolac (manufacturer unknown) which caused stomach problems and a history of knee replacement, who on 13-APR-2009 was vaccinated SC in the left deltoid with a 0.65mL dose of ZOSTAVAX (Merck) (lot number 663199/1551X). Concomitant therapy included aspirin a day, alprazolam, sertraline HCl, ranitidine, primidone, propranolol HCl, cyanocobalamin, ferrous SO4, omeprazole and gabapentin. On 25-APR-2009 the patient experienced itchy lesion on legs, arms, chest and back. The patient had very small lesions in which some were dry and some had fluid in the lesions. These were "discrete individual lesions" on legs, arms, chest and back. There were half a dozen on the chest and back but most of the lesions were on the legs. An unspecified nurse practitioner who examined the patient said it looked like chickenpox. The patient was taking BENADRYL prior to the office visit. The patient was given hydroxyzine for the itching. At the time of reporting the patient had not recovered from the events. Follow up information has been received from a pharmacist. The pharmacist reported that vesicles started on legs on 25-APR-2009 and then spread to another sites. The patient experienced a vesicular rash with many lesions on lower legs scattered, as well as scattered on torso and arms. As of 01-MAY-2009, the patient still had lesions. The patient was enrolled in the Varicella Zoster Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine VZV strain. The sample of the lesion was collected on 20-APR-2009 and 01-MAY-2009. The sample was taken from a vesicle and the site of specimen was not reported. The results were not provided. The pharmacist reported that patient had no recent exposure to chickenpox or shingles. Follow up information received revealed that the VZVIP specimen was inadequate, negative for B-globin, and no strain was identified. It was reported that the source of specimen was collected from a vesicle. The vesicles were very small and the scabs were very tight. It was unknown if any fluid was obtained in capillary tubes on 30-APR-2009. On 01-MAY-2009, the physician removed a scab and used a swab on the lesion. The VZV DNA was not amplified, neither the B-globin DNA. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning a patient who on an unspecified date was vaccinated with a 0.65mL dose of ZOSTER vaccine live (Merck) (route and lot number not reported).  The pharmacist reported that the patient developed a case of ZOSTER within one week following vaccination.  The patient sought medical attention by contacting the pharmacist.  This is one of several reports received from the same source.  Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning a patient who on an unspecified date was vaccinated with a 0.65mL dose of ZOSTAVAX (Merck) (route and lot number not reported).  The pharmacist reported that the patient developed a case of Zoster within one week following vaccination.  The patient sought medical attention by contacting the pharmacist.  This is one of several reports received from the same source.  Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Local reaction
Clinical narrative: Information has been received from a pharmacist concerning a 65 year old female who is the mother of an other healthcase professional in the same pharmacy. On 22-APR-2009 the patient was vaccinated with ZOSTAVAX (Merck). The patient experienced localized reaction like redness, pain and swelling on the same date after vaccination. This is one of several reports from the same source. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: Information has been received from a retired 72 year old female registered nurse with no medical history and drug allergy who in July 2007 was vaccinated with a dose of ZOSTAVAX vaccine (Merck). There was no concomitant medication. On 22-APR-2009, ten days ago, the patient developed shingles after receiving ZOSTAVAX vaccine (Merck). She developed the lesions on her back and around the front right of her chest. The lesions looked like "spider bites" and were very painful. At time of reporting, the patient was recovering. The patient saw the physician for medical attention. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 65 year old (also reported as 64 year old) female with hypertension, gastrooesophageal reflux disease (GERD), a history of anaemia, and allergies to Benadryl, DEMEROL, SUPRAX, NAPROSYN, IMITREX, SOMA who on 27-APR-2009 was subcutaneously vaccinated with 0.65 ml dose of ZOSTAVAX (Merck) (lot #663883/0132Y). Concomitant therapy included PROTONIX, HCTZ, NEURONTIN, RHINOCORT budesonide, SYMBICORT and montelukast sodium (MSD). On 01-MAY-2009 the patient developed injection site rash after receiving ZOSTAVAX (Merck). The rash was red, itchy and swollen. The patient did not recover at time of reporting. The patient called the practice for medical attention. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Information has been received from a registered pharmacist concerning a 63 year old female who was vaccinated with ZOSTAVAX (Merck) and experienced shingles after vaccination. The patient told the pharmacist that the vaccine didn't work on her. At the time of reporting, the outcome of the patient was unknown. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Varicella
Clinical narrative: Information has been received from a physician who was vaccinated with a dose of ZOSTAVAX vaccine (Merck). Two weeks later after receiving the ZOSTAVAX vaccine (Merck) the patient developed chickenpox. the patient sought unspecified medical attention. At the time of this report the patient had recovered. Additional information has been received.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia, Pain
Clinical narrative: Information has been received from a physician concerning himself who on 30-APR-2009 was vaccinated with ZOSTAVAX (Merck) by the intramuscular route. On 30-APR-2009 the patient developed generalized ache and myalgia which he was treating with ADVIL. It was unknown if the patient sought medical attention. At the time of reporting, the patient was not recovered. Follow-up information has been received from a physician concerning himself, a 61 year old male who on 30-APR-2009, at 17:00, was vaccinated with a first dose of ZOSTAVAX (Merck) at left deltoid. There was no medical history. The patient developed generalized myalgias for 2 days. It was unclear if generalized myalgia was a "normal" reaction to medication given. The patient didn't seek medical attention. Additional information is not expected.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a 73 year old female patient with sulfa allergy who in July 2008, was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included FUROSE and lisinopril (unspecified). On 25-APR-2009 the patient developed shingles. At the time of reporting the patient was recovering. No further information is available.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Body temperature increased, Herpes zoster, Pain, Pruritus, Tenderness
Clinical narrative: Information has been received from a licensed practical nurse concerning a 72 year old male patient with chronic obstructive pulmonary disease, arthritis, hypertension, hypercholesterolaemia and a history of hernia surgery, elevated liver enzymes caused by lovastatin (unspecified) and stomach upset caused by high doses of AUGMENTIN, who on 30-MAR-2009 was vaccinated S.Q. in his right upper arm with a 0.65 ml dose of ZOSTAVAX vaccine (Merck) (lot # 662858/1558X). Concomitant therapy included NEXIUM, DIOVAN, allopurinol as needed and simvastatin (unspecified). On 17-APR-2009 the patient developed 3 spots on the left side of his breast that looked like round blisters. The physician assistant sent in samples to a lab and the results came back positive for shingles. The patient was seen for an office visit but he has not required treatment. Follow-up information has been received from a physician assistant concerning the patient with no history of chickenpox and not recent exposure to it. It was reported that on 20-APR-2009 (previously reported on 17-APR-2009) the patient developed 3-4 small round spots that looked like blisters and seen to be spreading. The spots were painful. From a 0-10 scale, pain started at a 6 level going to a 9 level. The patient presented other systemic symptoms such as itching, and axilla tenderness. The maximum temperature was 97-98. On 24-APR-2009 herpes zoster was reported as positive per lab. No specimen was collected for PCR. No photos were taken. As of 08-MAY-2009 the patient had not completely recovered (had 5-6 red pindot spots) but was doing well. No further information is available.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Varicella zoster virus serology positive
Clinical narrative: Information has been received from a licensed practical nurse concerning a 72 year old male patient with chronic obstructive pulmonary disease, arthritis, hypertension, hypercholesterolaemia and a history of hernia surgery, elevated liver enzymes caused by lovastatin (unspecified) and stomach upset caused by high doses of AUGMENTIN, who on 30-MAR-2009 was vaccinated S.Q. in his right upper arm with a 0.65 ml dose of ZOSTAVAX vaccine (Merck) (lot # 662858/1558X). Concomitant therapy included NEXIUM, DIOVAN, allopurinol as needed and simvastatin (unspecified). On 17-APR-2009 the patient developed 3 spots on the left side of his breast that looked like round blisters. The physician assistant sent in samples to a lab and the results came back positive for shingles. The patient was seen for an office visit but he has not required treatment. Follow-up information has been received from a physician assistant concerning the patient with no history of chickenpox and not recent exposure to it. It was reported that on 20-APR-2009 (previously reported on 17-APR-2009) the patient developed 3-4 small round spots that looked like blisters and seen to be spreading. The spots were painful. From a 0-10 scale, pain started at a 6 level going to a 9 level. The patient presented other systemic symptoms such as itching, and axilla tenderness. The maximum temperature was 97-98. On 24-APR-2009 herpes zoster was reported as positive per lab. No specimen was collected for PCR. No photos were taken. As of 08-MAY-2009 the patient had not completely recovered (had 5-6 red pindot spots) but was doing well. No further information is available.
Age: 57.0
Sex: U
Vaccine: VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 57 year old patient who on 04-MAY-2009 inadvertently received ZOSTAVAX (Merck) instead of VARIVAX (Merck) (MSD). No symptoms reported. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Information has been received from a 67 year old female with allergies to estrogen, and FLUORENOL, post herpetic neuralgia and arthritis and a history of a fall on her left side a couple of years ago and shingles who on 04-APR-2009 was vaccinated with ZOSTER vaccine live (Merck).  Concomitant therapy included OXYCODONE, Aspirin and muscle relaxer.  About 2 to 3 days later the patient experienced pain on her left side.  At the time of the report, the patient did not recover and did not sought medical attention.  Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from the doctor's nurse concerning a 61 year old female who on 01-MAY-2009 was vaccinated subcutaneous injection, 0.65 ml, with ZOSTAVAX (Merck). Over the weekend the patient thought was running a fever, but didn't take her temperature. There was also a raised red spot at the injection site about 3-5 inches in diameter. The patient sought unspecified medical attention and was feeling "fine", but the spot was still there. The patient was recovering. Additional information has been requested.
Age: 1.5
Sex: M
Vaccine: VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a nurse practitioner concerning a 15 month old male who on 05-MAY-2009 was inadvertently vaccinated with a dose of ZOSTAVAX (Merck) due to a human error. No adverse effect reported. Follow up information received on 08-MAY-2009 from the nurse practitioner stated that the nurse who administered the dose of ZOSTAVAX (Merck) (lot # 662857/1560X) was a "float nurse" who does not routinely work at the office. The reporter indicated that the ZOSTAVAX (Merck) was stored on the same shelf as VARIVAX (Merck). According with the reporter the nurse forgot to double check so it was human error. It was also reported that "the vial was labeled correctly as ZOSTAVAX". The nurse practitioner spoke with the patient's mother and the patient was "doing well". Additional information is not expected.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Herpes virus infection
Clinical narrative: Information has been received from a physician concerning a 74 year old female patient with no pertinent medical history and no drug reactions or allergies who on 22-APR-2009 was vaccinated with ZOSTAVAX (Merck) (Lot# 663884/0131Y).  There was no concomitant medication.  After received the vaccine the patient experienced headache and herpectic lesions on her scalp.  The patient sought medical attention was seen at the practice.  At the time on the report on 05-MAY-2009 the patient had not recovered.  There were no laboratory diagnostics studies performed.  Additional information has been requested.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site irritation, Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: Information has been received from a doctor of pharmacy concerning a 64 year old female who in January 2009 was vaccinated with a 0.65ml dose of ZOSTAVAX (Merck) (lot number not reported). Subsequently the patient experienced itching, redness, burning, pain and a rash about 3 inches in diameter at the injection site. It lasted for about 2 weeks. As of 05-MAY-2009, there was a scar about 2 inches in diameter on the patient's arm. The patient had sought unspecified medical attention. At the time of reporting, the patient was recovering. Additional information has been requested.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site scar
Clinical narrative: Information has been received from a doctor of pharmacy concerning a 64 year old female who in January 2009 was vaccinated with a 0.65ml dose of ZOSTAVAX (Merck) (lot number not reported). Subsequently the patient experienced itching, redness, burning, pain and a rash about 3 inches in diameter at the injection site. It lasted for about 2 weeks. As of 05-MAY-2009, there was a scar about 2 inches in diameter on the patient's arm. The patient had sought unspecified medical attention. At the time of reporting, the patient was recovering. Additional information has been requested.
Age: 87.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood test, Herpes zoster, Pain, Pruritus
Clinical narrative: Information has been received from a 90 year old male who on 05-MAR-2007 was vaccinated with a dose of ZOSTAVAX (Merck). There was no concomitant medication. On approximately 29-APR-2009 the patient experienced shingles on his left side. The patient reported that it was not as painful as he thought shingles would be but very itchy. Unspecified "blood work" had been performed (result not reported). The patient had sought unspecified medical attention. At the time of reporting, the patient was not recovered. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a medical assistant who had been administering ZOSTAVAX (Merck) for the past 3-4 weeks. At the time of reporting the patient was experiencing chickenpox. The outcome of the medical assistant's chickenpox was not reported. Additional information has been requested.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Anorexia, Blister, Condition aggravated, Fatigue, Generalised erythema
Clinical narrative: Information has been received from a 58 year old female physician concerning herself with history of shingles while in her 20's who following her husband's vaccination on 02-APR-2009 with a dose of ZOSTAVAX (Merck) experienced zoster sine herpete associated sith S1 which began on 12-APR-2009. It was reported that she was fatigued and had loss of appetite. The patient had a zoster titer on 17-APR-2009 which came back with an IGG of 3.04. It was reported that the patient had not any treatment at the time of the report. The outcome of the patient was unknown. Follow up information was received from the physician who reported who reported that she definitely had involvement of L3 bilaterally and several adjacent thoracic dermatomes bilaterally. It was reported that she saw a transient rash in those dermatomes that only lasted about an hour that looked like generalized erythema with some 1 cm whit areas with central papules. It was reported that she saw about 10 clustered vesicles that were only about 1 mm in diameter on one leg. It was reported that everything was gone on an unspecified date. It was also reported that she had Chronic fatigue syndrome. The patient reported that she had been "ill" and has had worsening fatigue, which she initially thought was relapse of her chronic fatigue syndrome. It was reported that she believed that she may have "zoster sine herpete" and that her signs/symptoms were similar to those she experienced with her initial bout of shingles. She confirmed that she had not any treatment. That suggested that maybe "sine herpete" was really just  transient rash. It was reported that the patient had something like this the first time she had shingles. But she discounted the rash because it was so transient, and it was a lot less impressive than this time. It was reported that she was still trying to get to her physician to get this treated. Follow up information was received from the physician who stated what she continued to express concern regarding the "atypical" nature of her symptoms, and was seeking additional information. It was reported that she was alright, but that "some days, she just did not feel well". she reported that she has not had any new lesions. She also stated that she was seeing as Infectious Disease physician the following day on May 6th. This is one of several cases from the same source. Additional information has been requested.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Malaise, Rash, Rash papular, Secondary transmission, Varicella zoster serology negative
Clinical narrative: Information has been received from a 58 year old female physician concerning herself with history of shingles while in her 20's who following her husband's vaccination on 02-APR-2009 with a dose of ZOSTAVAX (Merck) experienced zoster sine herpete associated sith S1 which began on 12-APR-2009. It was reported that she was fatigued and had loss of appetite. The patient had a zoster titer on 17-APR-2009 which came back with an IGG of 3.04. It was reported that the patient had not any treatment at the time of the report. The outcome of the patient was unknown. Follow up information was received from the physician who reported who reported that she definitely had involvement of L3 bilaterally and several adjacent thoracic dermatomes bilaterally. It was reported that she saw a transient rash in those dermatomes that only lasted about an hour that looked like generalized erythema with some 1 cm whit areas with central papules. It was reported that she saw about 10 clustered vesicles that were only about 1 mm in diameter on one leg. It was reported that everything was gone on an unspecified date. It was also reported that she had Chronic fatigue syndrome. The patient reported that she had been "ill" and has had worsening fatigue, which she initially thought was relapse of her chronic fatigue syndrome. It was reported that she believed that she may have "zoster sine herpete" and that her signs/symptoms were similar to those she experienced with her initial bout of shingles. She confirmed that she had not any treatment. That suggested that maybe "sine herpete" was really just  transient rash. It was reported that the patient had something like this the first time she had shingles. But she discounted the rash because it was so transient, and it was a lot less impressive than this time. It was reported that she was still trying to get to her physician to get this treated. Follow up information was received from the physician who stated what she continued to express concern regarding the "atypical" nature of her symptoms, and was seeking additional information. It was reported that she was alright, but that "some days, she just did not feel well". she reported that she has not had any new lesions. She also stated that she was seeing as Infectious Disease physician the following day on May 6th. This is one of several cases from the same source. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: VARZOS
Symptoms: Secondary transmission, Varicella
Clinical narrative: Information has been received from a medical assistant concerning herself, a 24 year old female with a history of chickenpox at her 5 years old who on 04-MAY-2009 developed chickenpox lesion on her forearm after giving ZOSTAVAX (Merck) to 50 to 60 patients a week for 3 weeks. The patient had sought unspecified medical attention. At the time of reporting, she didn't recover. The patient thought that she developed chickenpox because she had been giving so many doses in a short period of time. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Body temperature increased, Pruritus, Rash maculo-papular, Viral DNA test negative
Clinical narrative: Initial and follow-up information has been received from a physician concerning a 68 year old female patient with hypertension, osteoporosis and DEMEROL allergy and history of chickenpox as a child who on 30-APR-2009 was vaccinated S.Q in her left arm with a dose of ZOSTAVAX (Merck) (lot # 663775/1789X). Concomitant therapy included TENORETIC, BONIVA, Omeprazole (unspecified) and (unspecified). On 01-MAY-2009 the patient experienced a maculo-papular rash with many erythematous lesions distributed on neck and trunk and progressing to the periphery to the proximal extremities. The lesions are itchy and the patient has excoriated the lesions. The patient's maximum temperature was 98.9. The patient has not presented any other systemic symptoms. The physician reported that the patient has not been recently exposed to chickenpox or shingles. On 5-MAY-2009 the patient presented to the office and specimen samples were taken. At the time of reporting the patient was recovering. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine VZV strain. Follow-up information has been received from physician concerning the patient. It was reported that the patient developed a rash which looked like early varicella. The physician stated that he was a bit concerned about the rash. It was confirmed that the patient did not experienced shingles since the rash was on both sides of the body. Information has been received from VZV identification program. On 05-MAY-2009 a sample of specimen was taken from scabs of the patient's rash. On 14-MAY-2009 date of PCR analysis was done. The sample was inadequate and no strain was identified. No further information is available.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Information has been received from a Registered Pharmacist (R.Ph) concerning a 66 year old female patient who used KENALOG about 1 to 2 weeks for skin condition and no known drug allergies/drug reactions who on 04-MAY-2009 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot # 664092/0198Y) subcutaneously. It was reported that on 05-MAY-2009 the patient experienced redness, tenderness, swelling and itching at the site of injection. The area was about 2 inches by 2 inches. The patient sought medical attention via telephone. It was reported that the patient was taking diphenhydramine. There were no laboratory diagnostic tests performed. On 06-MAY-2009, the patient reported to the pharmacist that the area was no longer swollen but was still red and increased in size. It was reported that the patient was recovering at the time of the report. Additional information has been requested.